Nicardipine Hydrochloride (盐酸尼卡地平; Nicardipine; YC-93) 是一种钙通道拮抗剂,已被广泛应用于控制的严重高血压等疾病,缺血性中风,脑外伤,脑出血等。
Nicardipine is a dihydropyridine calcium-channel blocking agent used for the treatment of vascular disorders.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Harino S, et al. Invest Ophthalmol Vis Sci, 1992, 33(10), 2885-2890.
分子式 C26H30ClN3O6 |
分子量 515.99 |
CAS号 54527-84-3 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 92 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02271191 | Spinal Stenosis | Drug: Nicardipine | Yonsei University | Phase 4 | 2012-05-01 | 2014-10-21 |
NCT01810302 | Cerebral Vasospasm | Drug: Nicardipine hydrochloride|Drug: Preservative-free normal saline | University of Florida | Phase 2 | 2013-08-01 | 2014-08-18 |
NCT00528827 | Hypertension | Drug: Cardene I.V. | Facet Biotech | Phase 2 | 2007-09-01 | 2012-03-15 |
NCT00765648 | Hypertensive Urgency | Drug: nicardipine intravenous|Drug: Labetalol | The Cleveland Clinic|EKR Therapeutics, Inc | Phase 4 | 2008-10-01 | 2014-12-11 |
NCT00325793 | Hypertension | Drug: Nicardipine | OSF Healthcare System|PDL BioPharma, Inc. | Phase 4 | 2004-01-01 | 2006-05-12 |
NCT00409253 | Hypertension During Pre-Eclampsia | Drug: URAPIDIL (EUPRESSYL*)|Drug: NICARDIPINE | University Hospital, Strasbourg, France | Phase 3 | 2007-06-01 | 2009-02-24 |
NCT02558023 | Hypertension|Preeclampsia | Drug: Urapidil|Drug: Nicardipine | University Hospital, Strasbourg, France | Phase 3 | 2015-09-01 | 2015-09-22 |
NCT01872039 | Hypertension Emergency|End-organ Damage | Drug: Perdipine injection | Astellas Pharma China, Inc.|Astellas Pharma Inc | Phase 4 | 2013-03-01 | 2015-11-13 |
NCT01951950 | Brain Tumors | Drug: Nicardipine|Drug: Esmolol | Northwestern University | Phase 1 | 2013-09-01 | 2014-08-28 |
NCT00508118 | Aortic Aneurysm, Thoracic | Drug: Nicardipine|Drug: 0.9% saline | Duke University | Phase 2 | 2008-01-01 | 2014-07-29 |
NCT01041066 | Patients Who Are Intubated for General Anesthesia|Endotracheal Intubation | Drug: labetalol|Drug: nicardipine | Seoul National University Bundang Hospital | 2009-09-01 | 2009-12-30 | |
NCT00415610 | Intracerebral Hemorrhage|Hypertension|Stroke | Drug: nicardipine | University of Minnesota - Clinical and Translational Science Institute|National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 | 2005-07-01 | 2015-08-10 |
NCT01176565 | Intracerebral Hemorrhage | Drug: Nicardipine hydrochloride | University of Minnesota - Clinical and Translational Science Institute|National Institute of Neurological Disorders and Stroke (NINDS)|Medical University of South Carolina|Johns Hopkins University|University of Michigan|Neurocritical Care Research Network|National Cerebral and Cardiovascular Center|Japan Cardiovascular Research Foundation|Beijing Tiantan Hospital|China Medical University Hospital|University Hospital Heidelberg|Seoul National University Hospital | Phase 3 | 2011-05-01 | 2016-09-30 |
NCT00093925 | Hypertension | Drug: clevidipine|Drug: nicardipine | The Medicines Company | Phase 3 | 2004-05-01 | 2014-05-05 |
NCT01175746 | Healthy Subjects | Drug: Nicardipine|Drug: remifentanil | Yonsei University | 2010-08-01 | 2013-06-11 | |
NCT01996436 | Cerebral Vasospasm | Drug: Nicardipine|Drug: Verapamil|Drug: Nicardipine + Verapamil + Nitroglycerin | The University of Texas Health Science Center, Houston|Yale University|University at Buffalo|Thomas Jefferson University|University of Illinois at Chicago|Mayo Clinic|Wake Forest University Health Sciences|Temple University|Geisinger Clinic|Northwell Health|University of Michigan|Brigham and Women's Hospital|Lenox Hill Hospital | Phase 4 | 2016-08-01 | 2016-10-25 |
NCT00490464 | Subarachnoid Hemorrhage|Intracerebral Hemorrhage | Drug: Nicardipine and Nipride | University of Illinois at Chicago | 2004-06-01 | 2007-06-21 | |
NCT01171911 | Acute Coronary Syndrome|Coronary Artery Disease | Drug: Nicardipine , Esmolol | Nanjing Medical University | Phase 4 | 2010-10-01 | 2010-07-28 |
NCT01634594 | Mandibular Prognathism,|Mandibular Retrognathism | Drug: Group R|Drug: Group N|Drug: Group D | Yonsei University | Phase 4 | 2012-06-01 | 2013-02-13 |
NCT02216747 | Glomerular Disease | Drug: prednisone 60 mg/meter square Body Surface Area|Drug: prednisone 45 mg|Drug: prednisone 30 mg | Rabin Medical Center | Phase 4 | 2014-09-01 | 2014-08-13 |
NCT02649413 | Nephrotic Syndrome, Minimal Change | Drug: Prednisone | Rabin Medical Center | Phase 4 | 2016-03-01 | 2016-01-11 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们